Medication and dietary supplement use and symptom severity of chemotherapy-induced peripheral neuropathy

Overview

https://research.qut.edu.au/cpc/https://research.qut.edu.au/cpc/

Chemotherapy-induced peripheral neuropathy (CIPN) is highly prevalent and clinically problematic, occurring in up to 60–80% of people receiving chemotherapy. Despite the high prevalence and significant patient and healthcare burden of CIPN, treatment options are limited.

This project will explore the association between medication and dietary supplement use and symptom severity of CIPN to identify factors that might worsen or improve CIPN symptoms.

Research activities

You will be involved in the preparation and analysis of a sub-set of baseline data from a large randomised controlled trial of 612 participants with CIPN. The project can be conducted on-site with the team in the Cancer and Palliative Care Outcomes Centre at QUT, or remotely.

Outcomes

This project will contribute to our understanding of the influence of neurotoxic chemotherapy, other medications, and dietary supplements on CIPN. Findings will guide future research to improve the prevention and management of CIPN.

You will gain experience with important research tasks, including skills in using SPSS software as well as data management, analysis and interpretation.

Skills and experience

The project would suit students with an interest in learning key research skills in data management and analysis, and/or an interest in cancer symptom management.

Scholarships

You may be eligible to apply for a research scholarship.

Explore our research scholarships

Keywords

• cancer
• chemotherapy
• neuropathy
• nutrition
• pharmaceuticals

Contact

Contact the primary supervisor (Dr. Megan Crichton) for more information.